Efficacy of infliximab in refractory Behçet’s disease-associated and idiopathic posterior segment uveitis: a prospective, follow-up study of 50 patients
Fabrizio Cantini1, Laura Niccoli1, Carlotta Nannini1, Olga Kaloudi1, Emanuele Cassarà1, Massimo Susini2, Ivo Lenzetti21Second Division of Internal Medicine, Rheumatology Unit, 2Division of Ophthalmology, Prato Hospital, Prato, ItalyPurpose: To evaluate the long-term efficacy of inflix...
Guardado en:
Autores principales: | Cantini F, Niccoli L, Nannini C, Kaloudi O, Cassarà E, Susini M, Lenzetti I |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3a4aa02e84c34d2d856f787356bd17bb |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Current trends in the management of ocular symptoms in Adamantiades-Behçet’s disease
por: Fouad R Zakka, et al.
Publicado: (2009) -
Neuro-Behçet’s disease: A report of sixteen patients
por: Radi Shahien, et al.
Publicado: (2010) -
Long-term efficacy and safety of infliximab and cyclosporine combination therapy for refractory uveoretinitis in Behçet’s disease
por: Katsuyama A, et al.
Publicado: (2019) -
Pattern of Uveitis Associated with Behçet’s Disease in an Egyptian Cohort
por: Abd El Latif E, et al.
Publicado: (2020) -
Sustained maintenance of clinical remission after adalimumab dose reduction in patients with early psoriatic arthritis: a long-term follow-up study
por: Cantini F, et al.
Publicado: (2012)